NK cell activity has often been shown to be impaired in AML patients; recent studies have demonstrated that NK-cell dysfunction may be related to the renin-angiotensin system (RAS) and that neurotransmitters seem to be crucial for the development of AML (113). This evidence concerns the gene REN and acute myeloid leukemia.